Premature decline of serum total testosterone in HIV-infected men in the HAART-Era

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Rochira, Vincenzo ^a   Zirilli, Lucia ^a   Orlando, Gabriella ^a   Santi, Daniele ^a   Brigante, Giulia ^a   Diazzi, Chiara ^a   Carli, Federica ^a   Carani, Cesare ^a   Guaraldi, Giovanni ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GONADOTROPIN; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; LUTEINIZING HORMONE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TESTOSTERONE;

ADULT; AGED; AGING; ANDROGEN DEFICIENCY; ARTICLE; BODY COMPOSITION; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; ERECTILE DYSFUNCTION; ESTRADIOL BLOOD LEVEL; GONAD FUNCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOGONADISM; HYPOPHYSIS GONAD SYSTEM; INTRAABDOMINAL FAT; LIPODYSTROPHY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; OSTEOPOROSIS; PREDICTION; SEXUAL BEHAVIOR; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; ADOLESCENT; BLOOD; COHORT ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PENIS ERECTION; PHYSIOLOGY; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; HIV INFECTIONS; HUMANS; HYPOGONADISM; LINEAR MODELS; MALE; MIDDLE AGED; PENILE ERECTION; TESTOSTERONE; YOUNG ADULT;

EID: 83055182227     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028512     Document Type: Article

References (51)

1. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, (2001) Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86: 724-731.
2. Kaufman JM, Vermeulen A, (1997) Declining gonadal function in elderly men. Baillieres Clin Endocrinol Metab 11: 289-309.
3. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C, (2006) Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 60: 762-769.
4. Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ, et al. (2010) Characteristics of Secondary, Primary, and Compensated Hypogonadism in Aging Men: Evidence from the European Male Ageing Study. J Clin Endocrinol Metab 95: 1810-1818.
5. Schneider HJ, Sievers C, Klotsche J, Böhler S, Pittrow D, et al. (2009) Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study. Clin Endocrinol 70: 446-454.
6. Araujo AB, Esche GR, Kupelian V, O'Donnell AB, Travison TG, et al. (2007) Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 92: 4241-4247.
7. Rietschel P, Corcoran C, Stanley T, Basgoz N, Klibanski A, et al. (2000) Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin Infect Dis 31: 1240-1244.
8. Kalyani RR, Gavini S, Dobs AS, (2007) Male hypogonadism in systemic disease. Endocrinol Metab Clin North Am 36: 333-348.
9. Grinspoon S, Corcoran C, Lee K, Burrows B, Hubbard J, et al. (1996) Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. J Clin Endocrinol Metab 81: 4051-4058.
10. Dobs AS, Few WL 3rd, Blackman MR, Harman SM, Hoover DR, et al. (1996) Serum hormones in men with human immunodeficiency virus-associated wasting. J Clin Endocrinol Metab 81: 4108-4112.
11. Crum NF, Furtek KJ, Olson PE, Amling CL, Wallace MR, (2005) A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and management. AIDS Patient Care STDS 19: 655-671.
12. Crum-Cianflone NF, Bavaro M, Hale B, Amling C, Truett A, et al. (2007) Erectile dysfunction and hypogonadism among men with HIV. AIDS Patient Care STDS 21: 9-19.
13. Dubé MP, Parker RA, Mulligan K, Tebas P, Robbins GK, et al. (2007) Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384. Clin Infect Dis 45: 120-126.
14. Collazos J, Esteban M, (2009) Has prolactin a role in the hypogonadal status of HIV-infected patients? J Int Assoc Physicians AIDS Care 8: 43-46.
15. Klein RS, Lo Y, Santoro N, Dobs AS, (2005) Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis 41: 1794-1803.
16. Wunder DM, Fux CA, Bersinger NA, Mueller NJ, Hirschel B, et al. (2008) Swiss HIV Cohort Study. Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study. HIV Med 9: 427-432.
17. Moreno-Pérez O, Escoin C, Serna-Candel C, Portilla J, Boix V, et al. (2010) The determination of total testosterone and free testosterone (RIA) are not applicable to the evaluation of gonadal function in HIV-infected males. J Sex Med 7: 2873-2883.
18. Mylonakis E, Koutkia P, Grinspoon S, (2001) Diagnosis and treatment of androgen deficiency in human immunodeficiency virus-infected men and women. Clin Infect Dis 33: 857-864.
19. Brambilla DJ, Matsumoto AM, Araujo AB, McKinlay JB, (2009) The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab 94: 907-913.
20. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H, (2007) Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 92: 405-413.
21. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, et al. (2010) Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95: 2536-2559.
22. Sartorius GA, Handelsman DJ, (2010) Testicular dysfunction in systemic diseases. In: Nieschlag E, Behre HM, Nieschlag S, editors. Andrology Male Reproductive Health and Dysfunction Berlin Springer-Verlag pp. 339-364.
23. Handelsman DJ, (2011) An old emperor finds new clothing: rejuvenation in our time. Asian J Androl 13: 125-9.
24. Palella FJ, Cole FR, Chmiel JS, Riddler SA, Visscher B, et al. (2004) Anthropometrics and examiner-reported body habitus abnormalities in the Multicenter AIDS Cohort Study. Clin Infect Dis 8: 903-907.
25. Park YW, Heymsfield SB, Gallagher D, (2002) Are dual-energy X-ray absorptiometry regional estimates associated with visceral adipose tissue mass? Int J Obes Relat Metab Disord 26: 978-983.
26. Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, et al. (1982) Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 36: 172-177.
27. Ofotokun I, Weitzmann MN, (2010) HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture. Curr Opin Endocrinol Diabetes Obes 17: 523-529.
28. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, et al. (1997) The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49: 822-30.
29. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH, (1999) Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 54: 346-51.
30. Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, et al. (2004) Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 89: 5920-5926.
31. Martin J, Volberding P, (2010) HIV and premature aging: A field still in its infancy. Ann Intern Med 153: 477-479.
32. Kalyani RR, Dobs AS, (2007) Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes 14: 226-234.
33. Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, et al. (2010) Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 363: 123-35.
34. Rochira V, Zirilli L, Genazzani AD, Balestrieri A, Aranda C, et al. (2006) Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback. Eur J Endocrinol 155: 513-522.
35. Zirilli L, Orlando G, Diazzi C, Squillace N, Carani C, et al. (2008) Hypopituitarism and HIV-infection: a new comorbidity in the HAART era? J Endocrinol Invest 31: 33-38.
36. Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB, (2007) The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 92: 549-55.
37. Cotter AG, Powderly WG, (2011) Endocrine complications of human immunodeficiency virus infection: Hypogonadism, bone disease and tenofovir-related toxicity. Best Pract Res Clin Endocrinol Metab 25: 501-515.
38. Deeks SG, Phillips AN, (2009) HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 338: 288-92.
39. Önen NF, Overton ET, (2011) A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging. Curr Aging Sci 4: 33-41.
40. Shiels MS, Pfeiffer RM, Engels EA, (2010) Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med 153: 452-460.
41. Martin ME, Benassayag C, Amiel C, Canton P, Nunez EA, (1992) Alterations in the concentrations and binding properties of sex steroid binding protein and corticosteroid-binding globulin in HIV+patients. J Endocrinol Invest 15: 597-603.
42. Arver S, Sinha-Hikim I, Beall G, Guerrero M, Shen R, et al. (1999) Serum dihydrotestosterone and testosterone concentrations in human immunodeficiency virus-infected men with and without weight loss. J Androl 20: 611-618.
43. Wasserman P, Segal-Maurer S, Rubin D, (2008) Low sex hormone-binding globulin and testosterone levels in association with erectile dysfunction among human immunodeficiency virus-infected men receiving testosterone and oxandrolone. J Sex Med 5: 241-247.
44. McLachlan RI, (2010) Certainly more guidelines than rules. J Clin Endocrinol Metab 95: 2610-2613.
45. Ly LP, Sartorius G, Hull L, Leung A, Swerdloff RS, et al. (2010) Accuracy of calculated free testosterone formulae in men. Clin Endocrinol 73: 382-388.
46. Sartorius G, Ly LP, Sikaris K, McLachlan R, Handelsman DJ, (2009) Predictive accuracy and sources of variability in calculated free testosterone estimates. Ann Clin Biochem 46: 137-143.
47. Brambilla DJ, O'Donnell AB, Matsumoto AM, McKinlay JB, (2007) Intraindividual variation in levels of serum testosterone and other reproductive and adrenal hormones in men. Clin Endocrinol 67: 853-862.
48. Vermeulen A, Verdonck G, (1992) Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men. J Clin Endocrinol Metab 74: 939-942.
49. Gorman AA, Foley JM, Ettenhofer ML, Hinkin CH, van Gorp WG, (2009) Functional consequences of HIV-associated neuropsychological impairment. Neuropsychol Rev 19: 186-203.
50. Guaraldi G, Luzi K, Murri R, Granata A, De Paola M, et al. (2007) Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophy. Antivir Ther 12: 1059-1065.
51. Travison TG, Morley JE, Araujo AB, O'Donnell AB, McKinlay JB, (2006) The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab 91: 2509-13.